Search Results

ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

March 11, 2024

·

3 min read

Press Releases

The Colossal Foundation Donates $1.5M to the Wyss Institute at Harvard University to Advance Artificial Womb Technology for Wildlife Conservation

January 13, 2025

·

5 min read

Press Releases

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01

January 23, 2025

·

8 min read

Press Releases

Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference

January 14, 2025

·

1 min read

Biotech Bay

NTT Research Funds New Program with Harvard Center for Brain Science

NTT Research, Inc., a division of NTT, announced that the NTT Research Foundation, a 5013 organization, has made a gift to establish the Harvard University Center for Brain Science -NTT Fellowship Program in the new field of Physics of Intelligence.

April 11, 2024

·

6 min read

Press Releases

Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include Stanton Lab CNS Capsids through a License Agreement from the Broad Institute of MIT and Harvard

February 19, 2025

·

3 min read

Business

Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights

Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported first quarter 2024 financial results.

May 13, 2024

·

6 min read

Genetown

Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024

Harvard Bioscience, Inc. announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024.

May 23, 2024

·

1 min read

Business

Harvard Bioscience Announces First Quarter 2024 Financial ResultsStrong gross margin performance and focus on efficiency to support ongoing investments in growth

Harvard Bioscience, Inc. announced financial results for the first quarter ended March 31, 2024.

May 7, 2024

·

10 min read

Genetown

Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth

Harvard Bioscience, Inc. announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth.

April 9, 2024

·

2 min read